相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae -A Case-Control Study in a Low Prevalence Country
Arne Soraas et al.
PLOS ONE (2013)
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited
Gunnar Kahlmeter et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli
Niki Lampri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Emilia Titelman et al.
MICROBIAL DRUG RESISTANCE (2012)
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
David M. Livermore
KOREAN JOURNAL OF INTERNAL MEDICINE (2012)
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli
M. Tarnberg et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones
Umaer Naseer et al.
MICROBIAL DRUG RESISTANCE (2011)
Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Simon Auer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins
Mandy Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: A randomized controlled trial
Lars Bjerrum et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2009)
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline
J. Garau
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases
Christopher I. Birkett et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway
Stale Tofteland et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project
Sven A. Ferry et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2007)
Activity of mecillinam against ESBL producers in vitro
K Thomas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora
A Sullivan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increased treatment failure after 3-days′ courses of nitrofurantoin and trimethoprim for urinary tract infections in women:: a population-based retrospective cohort study using the PHARMO database
WG Goettsch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole
MB Kerrn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women
LE Nicolle et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection
N Frimodt-Moller
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Antibiotic failure in the treatment of urinary tract infections in young women
RA Lawrenson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora
Å Sullivan et al.
JOURNAL OF CHEMOTHERAPY (2001)
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases
W Sougakoff et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies
H Hvidberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Recurrent urinary tract infections in postmenopausal women
R Raz et al.
CLINICAL INFECTIOUS DISEASES (2000)
Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection
AP Menday
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
分享论文
